Key Takeaways
- • EliseAI commanded the largest funding round at $350 million, achieving a $4 billion valuation led by Andreessen Horowitz and Bessemer Venture Partners, with backing from Ontario Teachers' Pension Plan and other institutional investors; the AI workflow automation platform targets housing and healthcare operations including patient scheduling, billing, and intake processes.
- • Four health tech companies collectively raised approximately $780 million in September, signaling sustained institutional confidence in AI-driven healthcare infrastructure and administrative automation solutions despite broader market conditions.
- • Rightway Healthcare secured $155 million in Series E funding from Francisco Partners to expand AI capabilities in its 100% pass-through pharmacy benefit management model, which currently serves 45 Fortune 500 companies and demonstrates institutional investor appetite for PBM innovation.
- • Forus (formerly Tandem) raised $150 million in Series C funding at a $3 billion valuation, with backing from Bain Capital Ventures and a syndicate of 11 co-investors; the platform addresses the medication-to-treatment workflow gap across all 50 U.S. states and 85% of residential zip codes.
- • Thyme Care achieved a $2+ billion valuation following its $125 million Series E round, led by Morgan Health with participation from major health plan operators (Humana, CVS Health Ventures), reflecting consolidation of cancer care navigation into established insurance ecosystems.
Summary
September 2026 witnessed substantial capital deployment across the health technology sector, with four companies announcing funding rounds totaling approximately $780 million. The announcements reflect a sustained focus by institutional investors on AI-driven automation solutions that address operational inefficiencies across healthcare and housing systems.
EliseAI's $350 million Series funding round, valuing the New York-based company at $4 billion, represented the largest single transaction. The AI platform automates critical workflows including patient scheduling, intake, front-desk operations, billing, and maintenance across healthcare and housing sectors. The round was led by Andreessen Horowitz and Bessemer Venture Partners, with participation from Ontario Teachers' Pension Plan, Sapphire Ventures, and Navitas Capital—indicating strong institutional pension and growth capital support.
Rightway Healthcare, a New York City-based pharmacy benefit management and care navigation platform, raised $155 million in Series E funding led by Francisco Partners, with backing from Thrive Capital and Khosla Ventures. The company operates a transparent 100% pass-through PBM model serving 45 Fortune 500 companies, and stated the capital would be deployed toward expanding its AI capabilities and technology infrastructure.
Forus (formerly Tandem) secured $150 million in Series C funding at a $3 billion valuation, bringing total capital raised to over $300 million. Bain Capital Ventures led the round with participation from 11 co-investors including Thrive Capital, General Catalyst, Accel, and others. The platform automates administrative workflows between prescription and patient treatment initiation, covering insurance navigation and pharmacy logistics across all 50 states and serving providers in 85% of U.S. residential zip codes.
Thyme Care, a Nashville-based oncology care navigation platform founded in 2020, completed a $125 million Series E round, now valued at over $2 billion. Morgan Health led the financing with participation from Humana, CVS Health Ventures, and venture partners. The company provides cancer patients with care navigation, clinical support, and access to specialist networks across all 50 states, currently serving 10.5 million people. The round notably reflected participation from major insurance and healthcare operators, signaling potential downstream integration.
EliseAI's $350 million Series funding round, valuing the New York-based company at $4 billion, represented the largest single transaction. The AI platform automates critical workflows including patient scheduling, intake, front-desk operations, billing, and maintenance across healthcare and housing sectors. The round was led by Andreessen Horowitz and Bessemer Venture Partners, with participation from Ontario Teachers' Pension Plan, Sapphire Ventures, and Navitas Capital—indicating strong institutional pension and growth capital support.
Rightway Healthcare, a New York City-based pharmacy benefit management and care navigation platform, raised $155 million in Series E funding led by Francisco Partners, with backing from Thrive Capital and Khosla Ventures. The company operates a transparent 100% pass-through PBM model serving 45 Fortune 500 companies, and stated the capital would be deployed toward expanding its AI capabilities and technology infrastructure.
Forus (formerly Tandem) secured $150 million in Series C funding at a $3 billion valuation, bringing total capital raised to over $300 million. Bain Capital Ventures led the round with participation from 11 co-investors including Thrive Capital, General Catalyst, Accel, and others. The platform automates administrative workflows between prescription and patient treatment initiation, covering insurance navigation and pharmacy logistics across all 50 states and serving providers in 85% of U.S. residential zip codes.
Thyme Care, a Nashville-based oncology care navigation platform founded in 2020, completed a $125 million Series E round, now valued at over $2 billion. Morgan Health led the financing with participation from Humana, CVS Health Ventures, and venture partners. The company provides cancer patients with care navigation, clinical support, and access to specialist networks across all 50 states, currently serving 10.5 million people. The round notably reflected participation from major insurance and healthcare operators, signaling potential downstream integration.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.